Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,259 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical significance and risk factors of urethrovesical anastomotic urinary leakage following robot-assisted radical prostatectomy: a multi-institutional study.
Kakutani S, Takeshima Y, Yamada Y, Fujimura T, Nagamoto S, Enomoto Y, Hakozaki Y, Kimura N, Teshima T, Akiyama Y, Sato Y, Kawai T, Yamada D, Kume H. Kakutani S, et al. Among authors: kimura n. BMC Urol. 2021 May 3;21(1):75. doi: 10.1186/s12894-021-00844-1. BMC Urol. 2021. PMID: 33941161 Free PMC article.
Clinical significance and risk factors of International Society of Urological Pathology (ISUP) grade upgrading in prostate cancer patients undergoing robot-assisted radical prostatectomy.
Takeshima Y, Yamada Y, Teshima T, Fujimura T, Kakutani S, Hakozaki Y, Kimura N, Akiyama Y, Sato Y, Kawai T, Yamada D, Kume H. Takeshima Y, et al. Among authors: kimura n. BMC Cancer. 2021 May 4;21(1):501. doi: 10.1186/s12885-021-08248-y. BMC Cancer. 2021. PMID: 33947348 Free PMC article.
The association between the parameters of uroflowmetry and lower urinary tract symptoms in prostate cancer patients after robot-assisted radical prostatectomy.
Takeshima Y, Yamada Y, Takemura K, Kimura N, Hakozaki Y, Miyakawa J, Taguchi S, Akiyama Y, Sato Y, Kawai T, Yamada D, Fujimura T, Kume H. Takeshima Y, et al. Among authors: kimura n. PLoS One. 2022 Oct 6;17(10):e0275069. doi: 10.1371/journal.pone.0275069. eCollection 2022. PLoS One. 2022. PMID: 36201466 Free PMC article.
Prostate-specific antigen doubling time predicts the efficacy of site-directed therapy for oligoprogressive castration-resistant prostate cancer.
Kawai T, Taguchi S, Nozaki K, Kimura N, Oshina T, Iwaki T, Matsui H, Niimi A, Kamei J, Akiyama Y, Yamada Y, Sato Y, Yamada D, Kaneko T, Sawayanagi S, Nakayama H, Minamimoto R, Yamashita H, Miyazaki H, Fujimura T, Nakagawa T, Kume H. Kawai T, et al. Among authors: kimura n. Prostate Int. 2023 Dec;11(4):239-246. doi: 10.1016/j.prnil.2023.10.002. Epub 2023 Oct 21. Prostate Int. 2023. PMID: 38196558 Free PMC article.
2,259 results